A new study by Monash University medicine safety experts found the use of gabapentinoids—medicines widely used to treat ...

A new study by medicine safety experts found the use of gabapentinoids -- medicines widely used to treat neuropathic pain -- increased the risk of hip fractures, especially in older patients who were ...

Neuropathic pain refers to pain caused by damage or disease to the nervous system.Neuropathic pain differs in pattern from ...

With a history of spinal injury and having not undergone a surgical stabilization, a syrinx was suspected. A magnetic resonance imaging (MRI) study of the patient's cervical and thoracic spine was ...

Researchers have found pregabalin highly effective in reducing neuropathic pain and itch in recessive dystrophic epidermolysis bullosa (RDEB), the most prevalent and debilitating form ...

A new study from Monash University in Australia has found that gabapentinoids—commonly used drugs for treating neuropathic ...

Shares of Sangamo Therapeutics (NASDAQ:SGMO) rose 12% in post-market trading Tuesday after the company announced the FDA had ...

On the other hand, one symptom, cold allodynia for example, can be the result of various mechanisms in peripheral or central neuropathic pain. [25] Another point that is important to discuss is ...

Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...

Often seen as a safer alternative to opioids for the treatment of neuropathic pain, gabapentinoid use increased eightfold between 2012 and 2018, with one in seven Australians aged 80 and older ...

An example of its success was the anti-CCL17 asset, now in Phase II development at GSK for both osteoarthritis pain and diabetic peripheral neuropathic pain. The unmet need to treat pain in ...